Tetanus and trauma: A review and recommendations

Journal of Trauma - Injury, Infection and Critical Care

Volumn 58, Issue 5, 2005, Pages 1082-1088

  Rhee, Peter ^a,b,c   Nunley, Mary K ^a   Demetriades, Demetrios ^b   Velmahos, George ^b   Doucet, Jay J ^a,b  

^a Space and Naval Warfare Systems Center Pacific   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c LAC USC MEDICAL CENTER   (United States)

Author keywords

Guidelines; Immunizations; Immunoglobulins; Tetanus; Tetanus antitoxin; Tetanus toxoid; Vaccination; Wounds

Indexed keywords

DIPHTHERIA TETANUS TOXOID; IMMUNOGLOBULIN; TETANUS TOXOID;

ADULT; ANAPHYLAXIS; BRACHIAL PLEXUS NEUROPATHY; DIPHTHERIA; ERYTHEMA; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNIZATION; INCIDENCE; INJURY; NORTH AMERICA; PAIN; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SIDE EFFECT; TETANUS; TRAVEL; UNITED STATES; WOUND INFECTION;

ADULT; AGED; CHILD; CHILD, PRESCHOOL; HISTORY, 20TH CENTURY; HUMANS; IMMUNIZATION SCHEDULE; INFANT; PRACTICE GUIDELINES; TETANUS; TETANUS TOXOID; UNITED STATES; WOUND INFECTION;

EID: 20144369668     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000162148.03280.02     Document Type: Review

References (60)

1. Dietz V, Milstien JB, van Loon F, Cochi S, Bennett J. Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Bull World Health Organ. 1996;74:6l9-628.
2. World Health Organization. Tetanus (neonatal) worldwide reported cases, 1980-2002. [WHO Web site]. October 17, 2003. Available at: http://www.who.int/ vaccines/en/neotetanus.shtml. Accessed June 21, 2004.
3. Tetanus-Puerto Rico, 2002. MMWR Morb Mortal Wkly Rep. 2002; 51:613-615.
4. World Health Organization. Tetanus (total) reported cases. [WHO Web site]. March 31, 2003. Available at: http://www.who.int/ vaccines/globalsummary/ timeseries/tsincidencetet.htm. Accessed June 21, 2004.
5. Wesche HA, Overfield T. Tetanus immunity in older adults. Public Health Nurs. 1992;9:125-127.
6. Murphy SM, Hegarty DM, Feighery CS, Walsh JB, Williams Y, Coakley DP. Tetanus immunity in elderly people. Age Ageing. 1995; 24:99-102.
7. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med. 1995;332:761-766.
8. Alagappan K, Rennie W, Kwiatkowski T, Falck J, Silverstone F, Silverman R. Seroprevalence of tetanus antibodies among adults older than 65 years. Ann Emerg Med. 1996;28:18-21.
9. Yuan L, Lau W, Thipphawong J, Kasenda M, Xie F, Bevilacqua J. Diphtheria and tetanus immunity among blood donors in Toronto. CMAJ. 1997;156:985-990.
10. Centers for Disease Control and Prevention. Summary of provisional cases of selected notifiable diseases, United States, cumulative, week ending December 30, 2000. MMWR Morb Mortal Wkly Rep. 2000; 49(51):1167-1174.
11. Hippocrates. Medicine, Translated by Chadwick J, Mann WN. In: Lloyd GER, ed. Hippocratic Writings. London: Penguin Classics; 1978.
12. von Behring E, Kitasato S. The mechanism of diphtheria immunity and tetanus immunity in animals. 1890. Mol Immunol. 1991;28:1317, 1319-1317, 1320.
13. Kantha SS. The legacy of von Behring and Kitasato. Immunol Today. 1992;13:374.
14. McGrew RE, McGrew MP. Encyclopedia of Medical History. 124; 1985:235-236.
15. Glenn F. Tetanus: a preventable disease. Ann Surg. 1946; New York: McGraw-Hill 1030-1040.
16. United States Army. The Army Immunization Program: Preventative Medicine in World War II. Washington, DC: United States Government Printing Office, Medical Department, United States Army: 1955:287.
17. Adams EB, Laurence DR, Smith JWG. Tetanus. Oxford: Blackwell Scientific; 1969.
18. United States Army. The Army Immunization Program: Preventative Medicine in World War II. Washington, DC: United States Government Printing Office, Medical Department, United States Army; 1955:287.
19. Bleck TP. Tetanus: pathophysiology, management, and prophylaxis. Dis Mon. 1991;37:545-603.
20. Bleck TP. Pharmacology of tetanus. Clin Neuropharmacol. 1986; 9:103-120.
21. Farrar JJ, Yen LM, Cook T, et al. Tetanus. J Neurol Neurosurg Psychiatry. 2000;69:292-301.
22. Ernst ME, Klepser ME, Fouts M, Marangos MN. Tetanus: pathophysiology and management. Ann Pharmacother. 1997; 31:1507-1513.
23. LaForce FM, Young LS, Bennett JV. Tetanus in the United States (1965-1966): epidemiologic and clinical features. N Engl J Med. 1969;280:569-574.
24. Kefer MP. Tetanus. Am J Emerg Med. 1992;10:445-448.
25. Trujillo MH, Castillo A, Espana J, Manzo A, Zerpa R. Impact of intensive care management on the prognosis of tetanus: analysis of 641 cases. Chest. 1987;92:63-65.
26. Thwaites CL, Farrar JJ. Preventing and treating tetanus. BMJ. 2003; 326:117-118.
27. Cook TM, Protheroe RT, Handel JM. Tetanus: a review of the literature. Br J Anaesth. 2001;87:477-487.
28. Agarwal M, Thomas K, Peter JV, Jeyaseelan L, Cherian AM. A randomized double-blind sham-controlled study of intrathecal human anti-tetanus immunoglobulin in the management of tetanus. Natl Med J India. 1998;11:209-212.
29. Miranda-Filho DB, Ximenes RA, Barone AA, Vaz VL, Vieira AG, Albuquerque VM. Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route. BMJ. 2004;328:615.
30. Kerr J. Current topics in tetanus. Intensive Care Med. 1979;5:105-110.
31. Tsueda K, Oliver PB, Richter RW. Cardiovascular manifestations of tetanus. Anesthesiology. 1974;40:588-592.
32. Talan DA, Abrahamian FM, Moran GJ, et al. Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds. Ann Emerg Med. 2004;43:305-314.
33. National, state, and urban area vaccination levels among children aged 19-35 months: United States, 2002. MMWR Morb Mortal Wkly Rep. 2003;52:728-732.
34. Centers for Disease Control and Prevention. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1991;40(RR-10):1-28.
35. Centers for Disease Control and Prevention. General recommendation on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1994;43:1-38.
36. Centers for Disease Control and Prevention. Percentage of persons aged > 18 years who reported receiving influenza or pneumococcal vaccine or tetanus toxoid, by age and selected characteristics: National Health Interview Survey, United States, 1998. [CDC/NIP Web site]. 1 August 2003. Available at: http://www.cdc.gov/nip/ coverage/nhis/tables/general-98.pdf. Accessed June 22, 2004.
37. Centers for Disease Control and Prevention. Recommended adult immunization schedule by age group and medical conditions: United States, 2003-2004. [CDC/NIP Web site]. 1 August 2003. Available at: http://www.cdc.gov/ nip/recs/adult-schedule.pdf. Accessed June 11, 2004.
38. McQuillan GM, Kruszon-Moran D, Deforest A, Chu SY, Wharton M. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med. 2002; 136:660-666.
39. Kruszon-Moran DM, McQuillan GM, Chu SY. Tetanus and diphtheria immunity among females in the United States: are recommendations being followed? Am J Obstet Gynecol. 2004; 190:1070-1076.
40. Bunch TJ, Thalji MK, Pellikka PA, Aksamit TR. Respiratory failure in tetanus: case report and review of a 25-year experience. Chest. 2002;122:1488-1492.
41. Bardenheier B, Prevots DR, Khetsuriani N, Wharton M. Tetanus surveillance-United States, 1995-1997. MMWR CDC Surveill Summ. 1998 Jul 3;47(2)1-13.
42. Centers for Disease Control and Prevention. Tetanus: United States, 1985-1986. MMWR Morb Mortal Wkly Rep. 1987;36:477-481.
43. Pascual FB, McGinley EL, Zanardi LR, Cortese MM, Murphy TV. Tetanus surveillance: United States, 1998-2000. MMWR Surveill Summ. 2003;52:1-8.
44. Bowen TE, Bellamy R. Emergency War Surgery: Second United States Revision of The Emergency War Surgery NATO Handbook. Washington, DC: United States Government Printing Office; 1988.
45. Talan DA, Moran GJ. Tetanus among injecting-drug users: California, 1997. Ann Emerg Med. 1998;32:385-386.
46. Bardenheier B, Prevots DR, Khetsuriani N, Wharton M. Tetanus surveillance: United States, 1995-1997. MMWR CDC Surveill Summ. 1998;47:1-13.
47. Centers for Disease Control and Prevention. Tetanus among injecting-drug users: California, 1997. MMWR Morb Mortal Wkly Rep. 1998;47:149-151.
48. Alagappan K, Rennie W, Narang V, Auerbach C. Immunologic response to tetanus toxoid in geriatric patients. Ann Emerg Med. 1997;30:459-462.
49. United States Army. The Army Immunization Program: Preventative Medicine in World War II. Washington, DC: United States Government Printing Office, Medical Department, United States Army; 1955:287.
50. National Coalition for Adult Immunization. Tetanus Factsheet. [National Foundation for Infectious Diseases Web site] January 30, 2004. Available at: http://www.nfid.org/factsheets/tetanusadult.html. Accessed June 21, 2004.
51. Simonsen O, Badsberg JH, Kjeldsen K, Moller-Madsen B, Heron I. The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand [C]. 1986;94:77-82.
52. Balestra DJ, Littenberg B. Should adult tetanus immunization be given as a single vaccination at age 65? A cost-effectiveness analysis. J Gen Intern Med. 1993;8:405-412.
53. Hutchison BG, Stoddart GL. Cost-effectiveness of primary tetanus vaccination among elderly Canadians. CMAJ. 1988;139:1143-1151.
54. Centers for Disease Control and Prevention. Shortage of tetanus and diphtheria toxoids. MMWR Morb Mortal Wkly Rep. 2000;49:1029-1030.
55. Centers for Disease Control and Prevention. Resumption of routine schedule for tetanus and diphtheria toxoids. MMWR Morb Mortal Wkly Rep. 2002;24:529-530.
56. Furste W. Tetanus: a new threat. J Trauma. 2001;51:416-417.
57. Zun LS, Downey L. Tetanus immunization shortage in the United States. Am J Emerg Med. 2003;21:298-301.
58. Izurieta HS, Sutter RW, Strebel PM, et al. Tetanus surveillance: United States, 1991-1994. MMWR CDC Surveill Summ. 1997;46:15-25.
59. Gardner P. Issues related to the decennial tetanus-diphtheria toxoid booster recommendations in adults. Infect Dis Clin North Am. 2001; 15:143-153.
60. Centers for Disease Control and Prevention. General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Morb Mortal Wkly Rep. 2002;51(RR02):1-36.